Long COVID / Post-COVID — Definition, Epidemiology, Symptom Clusters

2. Long COVID / post-COVID — definition, epidemiology, symptom clusters

What do "Long COVID" and "post-COVID" mean?

The terms describe health problems that persist, newly appear or recur after an acute SARS-CoV-2 infection and cannot be explained by another diagnosis. In practice two time-based cut-offs are used: according to the English NICE guideline one speaks of "ongoing symptomatic COVID-19" for symptoms between weeks 4 and 12, and of "post-COVID syndrome" for symptoms lasting longer than 12 weeks [2]. The World Health Organization (WHO) defines the "post-COVID-19 condition" more narrowly by consensus: symptoms that are usually present three months after the onset of infection, last at least two months and cannot otherwise be explained [1]. "Long COVID" is often used as an umbrella term for all longer-lasting courses and is a term coined by affected people. Important: this is not a single, uniform disease but a collective term for very different symptom patterns, presumably with several, partly overlapping disease mechanisms; the underlying mechanisms (e.g. immune dysregulation, autoimmunity, endothelial/clotting changes, viral persistence, reactivation of other viruses) are the subject of research and have so far not been conclusively clarified [4]. The German-language care guidelines (AWMF S1 guideline) follow these definitions and stress the exclusion of other causes [3].

Epidemiology — how common is Long COVID?

Reliable frequency figures are difficult because studies use different definitions, follow-up periods, control groups and survey methods. The estimates for prevalence after a past infection therefore range from a few percent to over 10 % and depend strongly on study design [4]. Controlled studies that also record symptoms in non-infected comparison groups usually give lower values, because many symptoms (e.g. tiredness) are common in the general population anyway [5]. This methodological uncertainty should be kept in mind with all figures; individual percentage values should therefore be interpreted with caution.

Relatively consistent risk factors are: female sex, higher age, a severe acute course (especially hospital/intensive-care treatment), a high number of acute symptoms and certain pre-existing conditions [4]. (Note: Long COVID can also occur after a mild or outpatient-treated infection; a severe acute course is not a precondition.) Full vaccination before the infection is associated in several studies with a lower risk, and infections with later virus variants (Omicron) seem to lead to Long COVID less often than early variants — but both observations are not conclusively established [4]. Children and adolescents are, by current data, overall affected less often and mostly more mildly than adults, though the evidence here is limited [4]. A significant proportion of those affected improve over months, while in a minority the symptoms persist long-term [4].

Symptom clusters

Long COVID can affect several organ systems; the literature describes a very large number of different symptoms (over 200 in extensive surveys) [4]. In practice, frequently recurring clusters can be recognised:

• Fatigue and exertion intolerance: pronounced exhaustion that is not sufficiently relieved by sleep. Central to it is post-exertional malaise (PEM) — a worsening after physical or mental effort, often time-delayed (hours to days later). This pattern overlaps with chronic fatigue syndrome (ME/CFS) and has immediate consequences for activity management [4].
• Neurocognitive complaints: difficulties with concentration and memory ("brain fog"), word-finding problems, headaches, sleep disturbances [4].
• Autonomic dysregulation: racing heart, dizziness and complaints on standing up, in part in the sense of a postural tachycardia syndrome (POTS) [4].
• Cardiopulmonary symptoms: shortness of breath, chest pain, exertional dyspnoea, palpitations [4].
• Others: muscle and joint pain, smell/taste disturbances, gastrointestinal complaints, skin changes and mood changes [4].

These clusters can occur singly or in combination and can change over time.

Warning signs — have them checked by a doctor: symptoms such as new or severe chest pain, acute/increasing shortness of breath, fainting or near-fainting, racing heart at rest, neurological deficits (e.g. paralysis, speech or vision disturbances), signs of a thrombosis (one-sided swollen, painful leg) or pronounced mental crises/suicidal thoughts are not "typical Long COVID complaints that you can wait out", but require prompt — and for acute complaints emergency — medical assessment. Cardiac and pulmonary causes must be ruled out.

Note on therapy and medications

For Long COVID there is so far no approved, causal drug therapy. Care is symptom-oriented and relies above all on activity and energy management ("pacing"), especially where PEM has been shown, as well as on treating individual complaints [2][3].

Important safety note on activity: where PEM is present, a forced, stepwise escalating training programme ("graded exercise therapy", GET) can worsen the symptoms; "pushing through" or "training against the exhaustion" is not recommended in PEM. The aim of pacing is to stay within the individual exertion limit and to avoid overexertion (crashes). Increases in activity should be made only cautiously, in a symptom-oriented way and ideally with medical/therapeutic guidance.

Substances under discussion — for example low-dose naltrexone (LDN, presumed mechanism via immune modulation/microglia) — are used exclusively off-label and within studies; the evidence is limited to small, in part uncontrolled investigations and is low or insufficient for a general recommendation [4]. Many over-the-counter (OTC) food supplements also lack solid proof of efficacy. Every drug measure can have side effects and interactions and belongs in a doctor's hands — this text does not replace individual advice and deliberately contains no dosing instruction and no promise of a cure. Central to it all remains the careful exclusion of treatable differential diagnoses [3].

Note: the references [1]–[5] point to established reference types (WHO, NICE, AWMF guideline as well as review/controlled studies). Their content was checked for plausibility, but within this check they could not be read against in full text; the specific figures and association statements should be understood as orientation and checked against the primary sources before further use (e.g. in a conversation with your doctor).